个性化问题:基于多种维生素和多种矿物质的癌症预防中性别的影响
Julij Šelb1,2, Filip Cvetko3, Leon Deutsch3
1The NU B.V., J.H. Oortweg 21, 2333CH, Leiden, The Netherlands. julij.selb@thenu.com.
GeroScience
|August 10, 2023
概括
多种维生素和多种矿物质的补充剂降低了总体和男性的癌症发病率,但不是女性. 这些发现表明,性别影响这些补充剂在预防癌症方面的有效性.
科学领域:
- 营养科学 营养科学
- 预防医学 预防医学
- 在瘤学瘤学.
背景情况:
- 非传染性疾病,如癌症,是健康衰老的一个主要问题.
- 食补充剂,包括多种维生素和多种矿物质 (MVM) 配方,正在研究它们在预防疾病中的潜在作用.
- 个体特征,如性别,可能会调节MVM补充剂的疗效.
研究的目的:
- 调查性别对多维生素多矿物质 (MVM) 补充剂预防癌症疗效的影响.
- 进行针对癌症发病率减少的MVM补充试验的性别特异性元分析.
主要方法:
- 对来自三个主要临床试验 (COSMOS,SU.VI.MAX,PHS2) 的数据进行了元分析.
- 这项分析共包括28558名男性和20542名女性.
- 固定效应 (FE) 和随机效应 (RE) 模型被用于元分析.
主要成果:
- 补充MVM显著降低了总人口中的癌症发病率 (HR 0.93 [95% CI,0.88-0.99]).
- 性别特定的分析显示,男性有显著的益处 (HR 0.91 [95% CI,0.85-0.97] FE;HR 0.88 [95% CI,0.77-1.01] RE).
- 在女性中没有观察到对癌症发病率的显著影响 (HR 1.00 [95% CI,0.88-1.14]).
结论:
- 性似乎是影响MVM补充剂预防癌症有效性的重要因素.
- 补充MVM证明了预防癌症的效果,主要在男性身上.
- 这些发现对未来的研究方向和公共卫生政策有关补充策略的影响.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
403
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


